Tag: DAWN

Day One Biopharmaceuticals NASDAQ DAWN Initial Data Phase 2 FIREFLY Trial Tovorafebib Spotlight Growth

Day One Biopharmaceuticals (NASDAQ: DAWN) Reports Positive Results from its FIREFLY-1 Clinical Trial of Tovorafenib

by admin

June 13, 2022

Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) is engaged as a clinical-stage biopharmaceutical company, which is focused on the research, development ...

No Result

View All Result

Home
News
Video
Stock and Crypto Screener

Tag: DAWN

Day One Biopharmaceuticals (NASDAQ: DAWN) Reports Positive Results from its FIREFLY-1 Clinical Trial of Tovorafenib

Asure Software (NASDAQ: ASUR) is Expanding to Meet the Rising Demand for Human Capital Management Software

OLB Group (NASDAQ: OLB) and Cuentas (NASDAQ: CUEN) Team Up to Bring Fintech Solutions to Over 32,000 Bodegas Across the United States

New Purchase Orders for SD7 Rugged Device, VK7, and Other Accessories Boost Siyata Mobile’s Outlook (NASDAQ: SYTA)

Telcoin (TEL) Quietly Leads a Crypto Remittance Revolution

Cybersecurity Stocks Coming Into Focus Amid High-Profile Attacks

Safe-T (NASDAQ: SFET) Has Been Selected to Present at the United Nations’ Office of Information and Communications Technology Event

Safe-T Group (NASDAQ: SFET) Reports Fourth Quarter and Full Year 2020 Financial Results

Safe-T Group Ltd. (NASDAQ: SFET) Estimates Record-High Annual Revenues of Approximately $4.9 Million Representing ~50% Growth YoY 2020

Innovative Eyewear (NASDAQ: LUCY) Debuts Lucyd Lyte 2.0 Audio Eyewear Product

American Resources Corporation (NASDAQ: AREC) Reduces Debt by Over $9 Million

It’s All Greek to Me: What Are Option Greeks and How Do They Impact Traders?

Unleashing the Power of 5G: The Future of Mobile Technology

Recent News

Innovative Eyewear (NASDAQ: LUCY) Debuts Lucyd Lyte 2.0 Audio Eyewear Product

American Resources Corporation (NASDAQ: AREC) Reduces Debt by Over $9 Million

Categories

Site Navigation